PPIDT00428
Drug Information
| Name | Bulevirtide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB15248 |
| Type | biotech |
| Indication | Bulevirtide is indicated for the treatment of chronic Hepatitis D infection in HDV-RNA positive adult patients with compensated liver disease.[L30215] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | Subcutaneous |
2 mg
|
| Injection, powder, for solution | Subcutaneous |
2 MG/vial
|